COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Athos Therapeutics develops AI-driven computational chemistry platforms that integrate clinical and molecular datasets into a disease interactome to discover small-molecule therapeutics; lead compound ATH-63 entering Phase Ia.